Loading...

Program Description

The objective of the inaugural Cancer Genomics and Tumor Immunotherapy Symposium: A Clinical Perspective is to provide academic and community oncologists, pharmaceutical leaders, regulatory agencies, basic and translational scientists and trainees with a clinical and translational perspective on genomics and immunotherapy as it applies to precision cancer medicine at the point of care. International, national, and local speakers will educate participants on emerging therapies and technologies, novel genomic approaches for diagnosis, the clinical development of tumor-derived DNA as a biomarker for cancer, immunogenomic-based drug development, response and resistance mechanisms to immune checkpoint therapy, and precision oncology for young people.

Program Outline

Accrediting Body/Accrediting Bodies

Loading...
Thank you for your interest in this program. Unfortunately, the program you have selected is currently not open for registration. Please complete a Program Inquiry so that we may promptly notify you when registration opens.
Required fields are indicated by .